Lexicon Pharmaceuticals, Inc. (LXRX) Trades at $14.94 After Triangle; Last Week Tourmaline Oil (TSE:TOU) Analysts

June 7, 2017 - By Hazel Jackson

Among 6 analysts covering Tourmaline Oil (TSE:TOU), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Tourmaline Oil had 27 analyst reports since July 21, 2015 according to SRatingsIntel. On Wednesday, March 8 the stock rating was maintained by Scotia Capital with “Outperform”. The company was maintained on Tuesday, May 30 by BMO Capital Markets. TD Securities maintained the stock with “Buy” rating in Friday, February 24 report. The rating was downgraded by BMO Capital Markets to “Market Perform” on Tuesday, December 22. The stock has “Buy” rating by TD Securities on Wednesday, March 8. On Friday, February 24 the stock rating was maintained by Scotia Capital with “Outperform”. The stock of Tourmaline Oil Corp (TSE:TOU) has “” rating given on Monday, June 6 by Raymond James. See Tourmaline Oil Corp (TSE:TOU) latest ratings:

30/05/2017 Broker: BMO Capital Markets Rating: Outperform New Target: $36.00 Maintain
05/05/2017 Broker: RBC Capital Markets Rating: Outperform Old Target: $42.00 New Target: $40.00 Target Down
13/04/2017 Broker: GMP Securities Rating: Old Target: $51.50 New Target: $50.00 Target Down
08/03/2017 Broker: Scotia Capital Rating: Outperform New Target: $41.00 Maintain
08/03/2017 Broker: TD Securities Rating: Buy New Target: $44.00 Maintain
24/02/2017 Broker: Scotia Capital Rating: Outperform New Target: $41.00 Maintain
24/02/2017 Broker: TD Securities Rating: Buy New Target: $44.00 Maintain
15/12/2016 Broker: RBC Capital Markets Rating: Old Target: $40.00 New Target: $42.00 Target Up

Lexicon Pharmaceuticals, Inc. (LXRX) formed triangle with $16.14 target or 8.00% above today’s $14.94 share price. Lexicon Pharmaceuticals, Inc. (LXRX) has $1.55B valuation. The stock increased 0.47% or $0.07 during the last trading session, reaching $14.94. About shares traded. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) has risen 17.98% since June 7, 2016 and is uptrending. It has outperformed by 1.28% the S&P500.

Tourmaline Oil Corp. is a Canada-based intermediate natural gas and crude oil exploration and production company. The company has market cap of $7.69 billion. The Firm is engaged in the acquisition, exploration, development and production of petroleum and natural gas properties. It has a 74.22 P/E ratio. The Firm is focused on exploration and acquisition program in the Western Canadian Sedimentary Basin.

The stock increased 2.95% or $0.81 on June 6, reaching $28.23. About 728,688 shares traded or 34.33% up from the average. Tourmaline Oil Corp (TSE:TOU) has 0.00% since June 7, 2016 and is . It has underperformed by 16.70% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

  • Cardinal Capital Management Upped Mb Financial New (MBFI) Holding, Last Week Equity One, Inc. (EQY) Coverage
  • Prospector Partners Has Increased By $730,300 Its United Technologies (UTX) Holding; KLA-Tencor (KLAC) Had 8 Bulls
  • Taylor Asset Management Trimmed By $557,600 Its Royal Caribbean Cruises LTD (RCL) Stake; 6 Analysts Covering Breedon Group PLC (LON:BREE)
  • Egerton Capital Uk Llp Decreased Facebook (FB) Position By $174.26 Million, Last Week Integer Holdings (GB) Coverage
  • Spf Beheer Bv Decreased By $1.10 Million Its 3M Co (MMM) Stake, Seaspan (SSW) Shorts Lowered By 7.03%
  • New Jersey Resources (NJR) Touches $43.35 High on Jun, 9; Oaktree Capital Management LP Lowered By $5.99 Million Its Nacco Industries (NC) Position
  • Melvin Capital Management LP Has Cut Netflix (NFLX) Holding, Renaissance Technologies Decreased By $3.44 Million Its B & G Foods New (BGS) Stake
  • Kynikos Associates LP Has Trimmed Huntington Ingalls Inds (HII) Stake By $772,248, 3 Bullish Analysts Covering Abzena PLC (LON:ABZA)
  • G2 Investment Partners Management Trimmed Carbonite (CARB) Position By $2.85 Million; Longwood Capital Partners Upped Immunomedics (IMMU) Holding By $13.92 Million
  • Redwood Investments Has Lowered Its Exelon (EXC) Stake; Profile of 4 Analysts Covering Foxtons Group PLC (LON:FOXT)